Beech Tree Labs, Inc., founded in 2005, is a United States-based company operating in the Biopharma, Biotechnology, and Pharmaceutical industries. The company is dedicated to addressing unmet medical needs by restoring the body’s healthy equilibrium, a mission encapsulated in its slogan: "We address unmet medical needs affecting the life of millions of people by restoring the body’s healthy equilibrium."
Over its more than 15 years of existence, Beech Tree Labs has focused on developing proprietary formulations that modulate the body’s signals to restore balance. As of the last known financial activity, the company secured a $7.00M Series B investment on 09 December 2010. While specific investor details for this round are not disclosed, this investment underscores the potential recognition of the company's innovative approach in the industry.
Overall, Beech Tree Labs' focus on addressing crucial medical needs with significant market potential makes it a noteworthy entity in the realm of healthcare innovation.